Insider Trading & Ownership of Jean Jacques Bienaime

Location: Palo Alto, CA
Summary: The estimated net worth of Jean Jacques Bienaime is at least $57,757,623 dollars as of 12 Mar 2026. Jean Jacques Bienaime is the Director of BIOMARIN PHARMACEUTICAL INC and owns shares of BIOMARIN PHARMACEUTICAL INC (BMRN) stock worth about $55.58M. Jean Jacques Bienaime is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $1.27M. Jean Jacques Bienaime is the Director of Immunome Inc. and owns shares of Immunome Inc. (IMNM) stock worth about $827.8K. Jean Jacques Bienaime is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $83.5K.
Signature: /s/ Sandra Stoneman, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Jean Jacques Bienaime files a new Insider Trading report.

Ownership of Jean Jacques Bienaime

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
BMRN	BIOMARIN PHARMACEUTICAL INC	Director	$55,578,092			20 May 2024
INCY	INCYTE CORP	Director	$1,268,174			10 Jun 2025
IMNM	Immunome Inc.	Director	$827,843	+$208,724	+34%	10 Mar 2026
KROS	Keros Therapeutics, Inc.	Director	$83,514	+$22,420	+37%	09 Mar 2026

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.